EnBiotix: Polyphor AG: Polyphor and EnBiotix Announce Dosing of First Patient in a First-in-Human Clinical Trial of Inhaled Murepavadin

Ad hoc announcement pursuant to Art. 53 LRALLSCHWIL, SWITZERLAND / ACCESSWIRE / December 15, 2021 / Polyphor AG (SIX:POLN) and EnBiotix Inc. today announced that the first subjects have been dosed ...